Chief Scientific Officer · Zura Bio Ltd (ZURA)

Michael Howell

FY2023 is the first fiscal year CompBrief holds for Michael Howell as a named executive officer of Zura Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,625,991

Salary $394,167Stock awards $599,430Bonus $165,000

6th of 7 named executive officers at Zura Bio by FY2023 total.

7 named officers on file for Zura Bio, FY2023

Michael Howell’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Zura Bio’s whole pay program stands against its peers

  • Zura Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZURA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed September 13, 2024 (DEF 14A).

Free

Get Michael Howell’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Howell compensation by year

Zura Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Zura Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$394,167
Bonus$165,000
Stock awards$599,430
Option awards$1,458,944
Non-equity incentive$0
Pension and deferred compensation$0
All other$8,450
Total$2,625,991

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zura Bio Ltd DEF 14A filed September 13, 2024, accession 0001104659-24-099807, and prior-year filings.

How this page was built: the Zura Bio Ltd filed document, accession 0001104659-24-099807. Every figure is read from that document and cited to the page and table it appears in. Filed September 13, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU114,395$534,225—
Option190,659—$1.20

Per the Outstanding Equity Awards at Fiscal Year-End table in Zura Bio Ltd's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Zura Bio’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Someit SidhuFormer Chief Executive Officer$10,750,338
Kim DavisChief Legal Officer$4,867,284
Preston KlassenFormer President and Chief Operating Officer$4,558,274
Chris CabellFormer Chief Medical Officer and Executive Vice President$3,628,709
Verender BadialChief Financial Officer$3,470,527
Michael Howell · this pageChief Scientific Officer$2,625,991
Kiran NistalaChief Medical Officer and Head of Development$14,769

The full Zura Bio compensation record

free company brief

This page is one person within Zura Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zura Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Howell's compensation dossier · One-time report. No refunds.